Administration-related reactions following first-dose subcutaneous daratumumab to inform implementation of a 30-minute observation period
Year: 2026
Type: article
Study design: Observational Study
Institution: Northwell Health
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7224765493
